Cell Culture World Congress 2012 - list of speakers

Dr. Joachim Bär is currently Head of Manufacturing Science and Technology Upstream at Boehringer Ingelheim Pharma GmbH & Co. KG, where he is supporting successful product transfers, scale up, process improvement and trouble shooting, functional testing of raw materials of biopharmaceutical medicines for captive use and for contract manufacturing. ...

Kevin Bailey has 25 years of experience in the biopharmaceutical industry, 20 of those at Regeneron Pharmaceuticals, Inc.,where he is Vice President of Preclinical Manufacturing and Process Development. He is responsible for leading all development efforts for clinical and commercial-scale manufacturing processes for all antibodies and other...

Dr. Alain Bernard is currently Vice-President, Biopharmaceutical Process Sciences at UCB, overseeing process developments for new chemical and new biological entities as well as for life-cycle management of marketed products. He joined UCB in 2006, from Serono where he was Director of Process Development. He had joined Serono in 1998 and was...

Dr. Berthold Bödeker is Chief Scientist and heading pilot plants and cell culture at the CMC unit of Global Drug Discovery-Biological Development of Bayer Schering Pharma AG in Wuppertal, Germany, which is responsible for the technical development and clinical material production of microbial and mammalian proteins. Before that he held several...

Starting with an Engineering degree coupled with a doctorate in Physiology, Hervé Broly developed the manufacture of monoclonal antibodies for diagnostic reagent and therapeutical use at the Regional Blood Transfusion Center of Lille (France) from 1982 to 1991 and then at a subsidiary of Serono located in Bordeaux (France) from 1991 to 2003. ...

Christine DeMaria is a Senior Scientist in the Cell Line and Cell Culture Process Development group at Genzyme. Dr. DeMaria received her B.S. in Biology from Tufts University and her Ph.D. in Microbiology and Immunology from Wake Forest University School of Medicine. Since joining Genzyme in 2001, much of her work has focused on the optimization...

Dr. Dempsey is a Process Science Fellow for Gibco’s® PD-Direct™ Bioproduction Services. He is responsible for assisting European and Indian biopharmaceutical companies in developing products and processes for the manufacture of biological medicines. Dr. Dempsey is an acknowledged expert in the metabolism and physiology of industrially relevant...

Sam joined BD as Applications and Scientific Manager in 2010 having held positions at Oxford BioMedica, Medimmune and Cambridge Antibody Technology. Sam holds a BA in physiological sciences from Oxford University and an Engineering Doctorate from UCL. Sam has over 10 years experience in all aspects of upstream bioprocess development. Particular...

Dr. Philine Dobberthien is associate director in the Protein Science group of Boehringer Ingelheim Biopharmaceutical Division. Her team covers the development of economic and robust purification and formulation processes for mAb and non-mAb proteins. Starting from bench scale including upstream support, i.e. pool and clone selection, up to...

“Virginie Fabre is currently Head of Unit in the Downstream Process Development department at sanofi pasteur (Marcy l’Etoile, France). She is responsible for the development of purification processes for recombinants proteins expressed in bacterial hosts and viral vaccines produced in mammalian cell cultures. She has developed an expertise in...

Over 20 years experience in the Medical Device industry serving the Pharmaceutical and Biopharmaceutical Industry. At Irvine Scientific she is currently the Management Representative with oversight to the review functions of the Regulatory Affairs, Quality Assurance, Quality Control and Document Control areas. She holds a Bachelors degree in...

Born in Quebec City (Canada), Dr. Philippe-Alexandre Gilbert is a graduate of the department of biochemistry at the University of Ottawa . He pursued his education at Laval University where he obtained his masters degree in molecular biology and his doctorate in biochemical engineering. For over 14 years now Dr. Gilbert has built a solid...

I have joined Pharming in 2000 as part of the R&D organization and shortly after Genzyme’s acquisition; I became jointly responsible to start up a cell culture team and to equip the new laboratories. I have played an important role in the transfer, scale up and validation of the cell culture processes for Myozyme and Campath. My team has developed ...

José is a biochemist & biophysicist with considerable experience in cell culture, chemical engineering, and molecular biology including 15 years of industry experience. He joined Pfizer through the acquisition of Wyeth and currently holds the position of Principal Scientist within the Culture Process Development group in Biotherapeutics R&D. His ...

Ulrich Göpfert is a Senior Reseach Scientist in the Cell Line and Molecule Development department at Roche. Dr. Göpfert received his Diploma and Ph.D. in Biochemistry from the University of Tübingen, Germany. In 2002 he joined the Biologics Research group of Roche in Penzberg. Since then he has been involved in the pre-clinical development of...

Ingo Gorr received his Biology degree from the University of Wurzburg in Germany, followed by a PhD in the Molecular Cell Biology department at the Max-Planck-Institute of Biochemistry in Martinsried/Germany. His research focused on the discovery of a new mechanism to control sister chromatid separation in anaphase. In 2006 he joined...

Dr. Michael Jenkins has been with Catalent Pharma Solutions since February 2003. He served as Director of Business Development and Commercial Operations until he was promoted to VP of BD in 2006 and General Manager in 2009. During his tenure The Facility was acquired by Cardinal Health and became part of Catalent Pharma Solutions. Prior to...

Dr. Jönsson received training in Chemistry, Biochemistry and Molecular Biology at Lund University and Wake Forest University School of Medicine where he gained expertise in the oxidative stress field. Dr. Jönsson joined Metabolon in 2009 and is the Associate Director of Project Management where he leads a team of biochemists focused on...

Thomas graudated from the University of Mainz in Germany, where he finished his PhD thesis in the field of cytokine research in 2001. Thereafter, he joined Dyax in Liege/Belgium, focusing on high through-put re-formatting of phage library derived Fabs to IgG antibodies and mammalian expression vectors before he took a position at the University of ...

Professor Jungbauer is a University Lecturer for Protein technology and Downstream processing. His teaching activities at the University, as well as in numerous workshops around the world focus in the area of protein production, isolation and the development for separation of biomolecules. He is currently working in the field of bioengineering of...

Dr. Eric Kurzhals presents a cutting edge CHO cell culture medium. Dr. Eric Kurzhals is currently Head of Process Development at Cellca GmbH. In this role he is responsible for cell culture media development and small scale process development for later transfer and application in large scale. He studied Biotechnology at the Mannheim University of ...

Dr Alvin W Nienow, Emeritus Professor of Biochemical Engineering at The University of Birmingham, UK is also a Visiting Professor of Biochemical Engineering at Loughborough University, UK. He has a PhD and DSc (Eng) from University College London (UCL) and is a Fellow of the Institution of Chemical Engineers and of the Royal Academy of...

Tim is currently Manager of Fermentation for Roche Pharma Biotech Production in Penzberg, Germany. In this role he leads a team responsible for seed train cultivation, fermentation process analytics and serves as responsible production process owner. He is the single point of contact for internal and external fermentation analytics and seed train...

Alain Pralong obtained his doctorate in molecular and cellular biology at the University of Berne in 2000. His research into apoptosis was conducted jointly between the University and Novartis, where all laboratory-based investigations were carried out. From 2000 to 2004 he worked on manufacturing Adenovaccine clinical trial material at...

Dr. Patricia Ruiz Noppinger studied Biology at the Universidad Complutense of Madrid, Spain, and Paris-Lodron Universität in Salzburg, Austria. In 1994 she received her PhD from the Basel Institute for Immunology in Basel, Switzerland. Following this Patricia worked as a Postdoctoral fellow for EMBO and TMR-Marie Curie in the department of...

Thomas completed his PhD in Biochemistry and Biotechnology in 1992 at the Technical University of Braunschweig, Germany. After a year PostDoc he joined Genentech in 1993. At Genentech he was involved in the development of the first generation of commercial antibody processes and other recombinant proteins including Fc-fusions, proteases, viral...

Matthieu Stettler obtained a master degree from the ETH in Switzerland and joined the lab of Prof. Wurm at the EPFL in Switzerland to work on his thesis project in cell culture process development. In 2008, he joined Lonza Biologics in the UK where he was involved in lab-scale process development and implementing new technologies for improved cell ...

Dr. Sasa Stojkovic (36) is heading the bioprocess pilot department at the Sandoz Biopharmaceuticals Business Unit at Lek Pharmaceuticals in Menges, Slovenia, which is responsible for the bioprocess development, scale up and process transfer to clinical material production of mammalian proteins. Before that he has done his PhD on probiotic bacteria ...

Hartmut Tintrup received his Ph.D. in 1998 from Frankfurt University, Germany. After finishing his Ph.D. thesis at the Max-Planck-Institute for Brain Research in Frankfurt he worked first as a Research Scientist at Artemis Pharmaceuticals GmbH, Cologne and then at Exelixis Inc., South San Francisco, USA. In 2004, Hartmut joined the US subsidiary...

PROFESSOR NIGEL TITCHENER-HOOKER heads the Department of Biochemical Engineering at UCL where he directs the Centre for Innovative Manufacturing of Emerging Macromolecular Therapies. The Centre goals is to accelerate the development of biopharmaceutical processes and involves collaboration with an international consortium of 25 companies and...

Dr. Anne Tolstrup joined Boehringer-Ingelheim Biopharma in 2011 where she holds the position as Director for Cell Culture II in the Process Science department. Here, her group is dealing with all aspects of mammalian cell line development for manufacturing of therapeutic proteins, from vector construction over stable cell line generation to the...

Diploma in Biology, TU Munich in 1991. Main topic Microbiology PhD in natural sciences, TU Munich in 1995. Identification of Microorganisms with labeled rRNA targeted oligonucleotides. Development of several different detection systems. ETH Zurich 1995-1998 in the Institute for terrestrial sciences. Application of the developed methods in soil to...